Ellen Kick
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 17, 2026
From Lead to Clinical Candidate: Discovery of BMS-986331 as a Potent and Selective N-Formyl Peptide Receptor 2 Agonist.Pravin S Shirude, Daniel Cheney, Amit K Chattopadhyay
|Sep 18, 2024
Discovery and Optimization of Aryl Piperidinone Ureas as Selective Formyl Peptide Receptor 2 Agonists.Nicholas R Wurtz, Pravin S Shirude, Daniel L Cheney
|Oct 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction.John Lupisella, Stéphane St-Onge, Marilyn Carrier
|Jun 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists.Nicholas R Wurtz, James A Johnson, Andrew Viet
|May 15, 2020
Discovery of BMS-986235/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure.Yoshikazu Asahina, Nicholas R Wurtz, Kazuto Arakawa
|Aug 16, 2018
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.Franck Duclos, Lynn M Abell, David G Harden
Pageof 1
Frequent Collaborators
5 joint publications
Nicholas R Wurtz
4 joint publications
John Lupisella
3 joint publications
Ruth R Wexler
2 joint publications
Michel Bouvier
1 joint publications
Franck Duclos
1 joint publications
Sylwia Stachura
1 joint publications
Javed A Khan
1 joint publications
James A Johnson
1 joint publications
Pravin S Shirude
